跳至主要内容
临床试验/NCT00914199
NCT00914199已完成不适用

Stenting of Coronary Artery Stenoses With Significant Side Branches. Should we, or Should we Not, Perform Dilatation of the Side Branch Through the Main Vessel Stent, if There is Acceptable Blood Flow in the Side Branch?

Evald Hoej Christiansen2 个研究点 分布在 1 个国家目标入组 477 人开始时间: 2007年4月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
477
试验地点
2
主要终点
Combined end point of: cardiac death, index lesion myocardial infarction, stent thrombosis or target lesion revascularisation

研究概览

简要总结

Should we, or should we not, perform dilatation of the side branch through the main vessel stent, if there is acceptable blood flow in the side branch?

详细描述

Design:

  • Randomised open multicentre trial

Patients:

  • Number 477

Randomisation:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Stable or unstable angina pectoris. -Bifurcation lesion of "LAD/diagonal", "Cx/obtuse marginal", "RCA--
  • PDA/posterola¬te¬ral branch" or "LM/Cx/LAD".
  • Diameter of main vessel by visual estimate > 2.5 mm.
  • Diameter of side branch by visual estimate > 2.25 mm.
  • Signed informed consent

排除标准

  • Age < 18 years.
  • ST-elevation infarction within 24 hours.
  • Expected survival < 1 year.
  • S-creatinine > 200 µmol/l.
  • Allergy to Aspirin, Clopidogrel or Ticlopidine.
  • Allergy to Sirolimus.

结局指标

主要结局

Combined end point of: cardiac death, index lesion myocardial infarction, stent thrombosis or target lesion revascularisation

时间窗: After 6 months

次要结局

  • Cardiac death(during hospital period, after 1, 8 and 14 months, 2 and 3 years)
  • Stent thrombosis(during hospital period, after 1, 8 and 14 months, 2 and 3 years)
  • CCS angina score(after 1, 8 and 14 months, 2 and 3 years)
  • MACE (cardiac death, myocardial infarction, stent thrombosis or target vessel revascularisation)(during hospital period, after 1, 8, and 14 months, 2 and 3 years)
  • Myocardial infarction(related to the index procedure)
  • Target vessel revascularisation(during hospital period, after 1, 8 and 14 months, 2 and 3 years)
  • Total mortality(during hospital period, after 1, 6, 8 and 14 months, 2 and 3 years)
  • Target lesion revascularisation(during hospital period, after 1, 8 and 14 months, 2 and 3 years)
  • Angiographic significant stenosis (>50%) of main vessel and/or occlusion of the side branch(after 8 months)
  • Late loss of main vessel and side branch(after 8 months)
  • Angiographic significant stenosis (>50%) of main vessel(after 8 months)
  • Angiographic significant stenosis (>50%) of main vessel and/or side branch(after 8 months)
  • Angiographic significant stenosis (>50%) of side branch(after 8 months)
  • Markers(before and after the procedure)

研究者

发起方
Evald Hoej Christiansen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Evald Hoej Christiansen

MD

Aarhus University Hospital Skejby

研究点 (2)

Loading locations...

相似试验